| Rapid SARS-CoV-2 testing in primary material based on a novel multiplex RT-LAMP assay B Schermer, F Fabretti, M Damagnez, V Di Cristanziano, E Heger, ... PloS one 15 (11), e0238612, 2020 | 69 | 2020 |
| S-sulfocysteine/NMDA receptor–dependent signaling underlies neurodegeneration in molybdenum cofactor deficiency A Kumar, B Dejanovic, F Hetsch, M Semtner, D Fusca, S Arjune, ... The Journal of clinical investigation 127 (12), 4365-4378, 2017 | 66 | 2017 |
| Exonic microdeletions of the gephyrin gene impair GABAergic synaptic inhibition in patients with idiopathic generalized epilepsy B Dejanovic, D Lal, CB Catarino, S Arjune, AA Belaidi, H Trucks, ... Neurobiology of disease 67, 88-96, 2014 | 63 | 2014 |
| Favorable outcome in a newborn with molybdenum cofactor type A deficiency treated with cPMP MM Hitzert, AF Bos, KA Bergman, A Veldman, G Schwarz, ... Pediatrics 130 (4), e1005-e1010, 2012 | 54 | 2012 |
| Molybdenum Cofactor Deficiency: A New HPLC Method for Fast Quantification of S-Sulfocysteine in Urine and Serum AA Belaidi, S Arjune, JA Santamaria-Araujo, JO Sass, G Schwarz JIMD Reports-Case and Research Reports, 2012/2, 35-43, 2012 | 30 | 2012 |
| Oxygen reactivity of mammalian sulfite oxidase provides a concept for the treatment of sulfite oxidase deficiency AA Belaidi, J Röper, S Arjune, S Krizowski, A Trifunovic, G Schwarz Biochemical Journal 469 (2), 211-221, 2015 | 28 | 2015 |
| The role of glutamate oxaloacetate transaminases in sulfite biosynthesis and H2S metabolism AT Mellis, AL Misko, S Arjune, Y Liang, K Erdélyi, T Ditrói, AT Kaczmarek, ... Redox Biology 38, 101800, 2021 | 24 | 2021 |
| Magnetic resonance kidney parenchyma-T2 as a novel imaging biomarker for autosomal dominant polycystic kidney disease F Siedek, F Grundmann, K Weiss, DP Dos Santos, S Arjune, S Haneder, ... Investigative Radiology 55 (4), 217-225, 2020 | 19 | 2020 |
| RESET-PKD: a pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease S Oehm, K Steinke, J Schmidt, S Arjune, P Todorova, ... Nephrology Dialysis Transplantation 38 (7), 1623-1635, 2023 | 17 | 2023 |
| Involvement of the Cys-Tyr cofactor on iron binding in the active site of human cysteine dioxygenase S Arjune, G Schwarz, AA Belaidi Amino Acids 47, 55-63, 2015 | 17 | 2015 |
| Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2 SN Tammam, S El Safy, S Ramadan, S Arjune, E Krakor, S Mathur Journal of Controlled Release 337, 258-284, 2021 | 13 | 2021 |
| Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD—a randomized controlled trial S Cukoski, CH Lindemann, S Arjune, P Todorova, T Brecht, A Kühn, ... Cell Reports Medicine 4 (11), 2023 | 12 | 2023 |
| Cardiac manifestations in patients with autosomal dominant polycystic kidney disease (ADPKD): a single-center study S Arjune, F Grundmann, P Todorova, C Hendrix, R Pfister, ... Kidney360 4 (2), 150-161, 2023 | 7 | 2023 |
| Molybdenum cofactor catabolism unravels the physiological role of the drug metabolizing enzyme thiopurine S‐methyltransferase J Pristup, E Schaeffeler, S Arjune, U Hofmann, ... Clinical Pharmacology & Therapeutics 112 (4), 808-816, 2022 | 6 | 2022 |
| Automated kidney and liver segmentation in MR images in patients with autosomal dominant polycystic kidney disease: a multicenter study P Woznicki, F Siedek, MDA van Gastel, DP Dos Santos, S Arjune, ... Kidney360 3 (12), 2048-2058, 2022 | 5 | 2022 |
| Interaction between determinants governing urine volume in patients with ADPKD on tolvaptan and its impact on quality of life P Todorova, S Arjune, C Hendrix, S Oehm, J Schmidt, D Krauß, K Burkert, ... Kidney International Reports 8 (8), 1616-1626, 2023 | 3 | 2023 |
| KETO-ADPKD: a randomized, controlled trial on ketogenic dietary interventions in autosomal dominant polycystic kidney disease S Cukoski, C Lindemann, T Brecht, A Kühn, S Arjune, P Todorova American Society of Nephrology Kidney Week, 3-6, 2022 | 3 | 2022 |
| Matrix Metalloproteinase-7 in Urinary Extracellular Vesicles Identifies Rapid Disease Progression in Autosomal Dominant Polycystic Kidney Disease MH van Heugten, CJ Blijdorp, S Arjune, H van Willigenburg, K Bezstarosti, ... Journal of the American Society of Nephrology, 10.1681, 2023 | 2 | 2023 |
| A low-cost sequencing platform for rapid genotyping in ADPKD and its impact on clinical care CH Lindemann, A Wenzel, F Erger, L Middelmann, J Borde, E Hahnen, ... Kidney International Reports 8 (3), 455-466, 2023 | 2 | 2023 |
| Cyst fraction as a biomarker in autosomal dominant polycystic kidney disease LA Karner, S Arjune, P Todorova, D Maintz, F Grundmann, T Persigehl, ... Journal of Clinical Medicine 12 (1), 326, 2022 | 2 | 2022 |
